Changeflow GovPing Pharma & Drug Safety Tooth Remineralisation Composition Patent
Routine Notice Added Final

Tooth Remineralisation Composition Patent

Favicon for changeflow.com ChangeBridge: EPO Bulletin - Pharma (A61K)
Published March 25th, 2026
Detected April 1st, 2026
Email

Summary

The European Patent Office published patent EP3668605A1 for Unilever covering methods of promoting tooth remineralisation. The patent names Unilever Global IP Limited and Unilever IP Holdings B.V. as applicants, with three named inventors. No compliance obligations arise from this publication.

What changed

The EPO published patent application EP3668605A1 titled 'Method of Promoting Remineralisation of Teeth' on behalf of Unilever entities. The patent covers compositions and methods for tooth remineralisation using specific active ingredients (A61K 8/21 - fluoride compounds, A61K 8/26, A61K 8/49). Designated states cover the full EU membership plus EEA countries.

This patent publication is informational and does not impose compliance obligations on competitors or other parties. Companies in the oral care, dental, or consumer health products sector should review the claims to assess potential freedom-to-operate implications for their own tooth remineralisation or fluoride-based oral care products. No immediate action is required.

Source document (simplified)

← EPO Patent Bulletin

METHOD OF PROMOTING REMINERALISATION OF TEETH

Publication EP3668605A1 Kind: A1 Mar 25, 2026

Applicants

Unilever Global IP Limited, Unilever IP Holdings B.V.

Inventors

CHANDRASEKARAN, Sembian, IYER, Meenakshi, TRIVEDI, Neha

IPC Classifications

A61Q 11/00 20060101AFI20190222BHEP A61K 8/26 20060101ALI20190222BHEP A61K 8/02 20060101ALI20190222BHEP A61K 8/49 20060101ALI20190222BHEP A61K 8/21 20060101ALI20190222BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
EPO
Published
March 25th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
EP3668605A1

Who this affects

Applies to
Manufacturers Consumers
Industry sector
3254 Pharmaceutical Manufacturing
Geographic scope
European Union EU

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Healthcare Consumer Protection

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: EPO Bulletin - Pharma (A61K) publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.